![Erik Berglund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Erik Berglund formerly worked at Gilead Sciences, Inc., as Senior Director-Regulatory Affairs and Vistagen Therapeutics, Inc., as Senior Vice President-Global Regulatory Affairs from 2021 to 2025.
Dr. Berglund received his doctorate degree from Umea Universitet.
Tidigare kända positioner av Erik Berglund
| Företag | Position | Slut |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Generell Rådgivare | 2025-01-10 |
| GILEAD SCIENCES, INC. | Generell Rådgivare | - |
Erik Berglunds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
20
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Umea Universitet
 Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
